Metabolic syndrome pathophysiology: the role of adipose tissue - PubMed (original) (raw)
Review
Metabolic syndrome pathophysiology: the role of adipose tissue
Martin Laclaustra et al. Nutr Metab Cardiovasc Dis. 2007 Feb.
Abstract
Several pathophysiological explanations for the metabolic syndrome have been proposed involving insulin resistance, chronic inflammation and ectopic fat accumulation following adipose tissue saturation. However, current concepts create several paradoxes, including limited cardiovascular risk reduction with intensive glucose control in diabetics, therapies that result in weight gain (PPAR agonists), and presence of some of the metabolic traits among some lipodystrophies. We propose the functional failure of an organ, in this case, the adipose tissue as a model to interpret its manifestations and to reconcile some of the apparent paradox. A cornerstone of this model is the failure of the adipose tissue to buffer postprandial lipids. In addition, homeostatic feedback loops guide physiological and pathological adipose tissue activities. Fat turnover is determined by a complex equilibrium in which insulin is a main factor but not the only one. Chronically inadequate energy balance may be a key factor, stressing the system. In this situation, an adipose tissue functional failure occurs resulting in changes in systemic energy delivery, impaired glucose consumption and activation of self-regulatory mechanisms that extend their influence to whole body homeostasis system. These include changes in adipokines secretion and vascular effects. The functional capacity of the adipose tissue varies among subjects explaining the incomplete overlapping among the metabolic syndrome and obesity. Variations at multiple gene loci will be partially responsible for these interindividual differences. Two of those candidate genes, the adiponectin (APM1) and the perilipin (PLIN) genes, are discussed in more detail.
Similar articles
- [Adipokines and lipids].
Sumarac-Dumanović M, Jeremić D. Sumarac-Dumanović M, et al. Med Pregl. 2009;62 Suppl 3:47-53. Med Pregl. 2009. PMID: 19702116 Review. Serbian. - The role of perilipin in human obesity and insulin resistance.
Tai ES, Ordovas JM. Tai ES, et al. Curr Opin Lipidol. 2007 Apr;18(2):152-6. doi: 10.1097/MOL.0b013e328086aeab. Curr Opin Lipidol. 2007. PMID: 17353663 Review. - Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH, Ikura Y, Iezzoni JC, Liu Z. Caldwell SH, et al. J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S11-9. doi: 10.1111/j.1440-1746.2006.04639.x. J Gastroenterol Hepatol. 2007. PMID: 17567458 Review. - Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, Punnonen K, Vanninen E, Laakso M. Salmenniemi U, et al. Circulation. 2004 Dec 21;110(25):3842-8. doi: 10.1161/01.CIR.0000150391.38660.9B. Epub 2004 Dec 13. Circulation. 2004. PMID: 15596567 - Perilipin expression in human adipose tissue is elevated with obesity.
Kern PA, Di Gregorio G, Lu T, Rassouli N, Ranganathan G. Kern PA, et al. J Clin Endocrinol Metab. 2004 Mar;89(3):1352-8. doi: 10.1210/jc.2003-031388. J Clin Endocrinol Metab. 2004. PMID: 15001633
Cited by
- Association of single nucleotide polymorphism Rs2236518 in PRDM16 gene with BMI in Chinese males.
Yue H, He JW, Ke YH, Zhang H, Wang C, Hu WW, Gu JM, Fu WZ, Hu YQ, Li M, Liu YJ, Zhang ZL. Yue H, et al. Acta Pharmacol Sin. 2013 May;34(5):710-6. doi: 10.1038/aps.2012.201. Epub 2013 Mar 25. Acta Pharmacol Sin. 2013. PMID: 23524569 Free PMC article. - Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline.
Saravia G, Civeira F, Hurtado-Roca Y, Andres E, Leon M, Pocovi M, Ordovas J, Guallar E, Fernandez-Ortiz A, Casasnovas JA, Laclaustra M. Saravia G, et al. PLoS One. 2015 Aug 4;10(8):e0132244. doi: 10.1371/journal.pone.0132244. eCollection 2015. PLoS One. 2015. PMID: 26241903 Free PMC article. - The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity.
Torres-Perez E, Valero M, Garcia-Rodriguez B, Gonzalez-Irazabal Y, Calmarza P, Calvo-Ruata L, Ortega C, Garcia-Sobreviela MP, Sanz-Paris A, Artigas JM, Lagos J, Arbones-Mainar JM. Torres-Perez E, et al. Cardiovasc Diabetol. 2015 Apr 22;14:40. doi: 10.1186/s12933-015-0203-6. Cardiovasc Diabetol. 2015. PMID: 25896263 Free PMC article. - Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients.
Huang B, Yang S, Ye S. Huang B, et al. J Diabetes Res. 2020 Sep 5;2020:6538208. doi: 10.1155/2020/6538208. eCollection 2020. J Diabetes Res. 2020. PMID: 32964054 Free PMC article. - The role of receptor-interacting protein 140 in the accumulation of fat in ovariectomised rats.
Liu WH, Lee YM, Lam KK, Chen YF, Wang JJ, Yen MH, Cheng PY. Liu WH, et al. Obes Surg. 2011 Jul;21(7):935-40. doi: 10.1007/s11695-010-0241-9. Obes Surg. 2011. PMID: 20680503
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous